Schedule 13G ownership disclosure

PORTOLA PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 737010108

Event date: 2017-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,659,571
Percent of class
10.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000498
Form type
SC 13G/A
Filer
PORTOLA PHARMACEUTICALS INC
CIK
CIK 1269021
Filed
Feb 10, 2017
Reporting period
Jan 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub